Elbit Systems Ltd. (ESLT) Stock Analysis
Is ESLT a good investment?
Elbit Systems Ltd. (ESLT) has a Plutrex AI rating of 65.0/100 as of August 21, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Fortress balance sheet: D/E of 0.15x (83% below industry average of 0.88x), $963M cash, near-zero financial distress risk — provides strategic flexibility for acquisitions and R&D while peers are heavily leveraged; ROE of 15.23% exceeds industry average of 14.04% achieved entirely without financial engineering. Main concern: Valuation remains materially elevated: PEG 1.96x (25.5% premium to industry 1.56x, ~96% above fair value 1.0x), P/E 56.10x on 7.4% net margins — analyst consensus target $854.45 implies only 14.9% upside, insufficient compensation for execution risk at this multiple; growth-adjusted fair value range remains $480-$600, implying 19-35% downside from current price.
Investment Summary
Elbit Systems (ESLT) at $743.67 is a high-quality Israeli defense/aerospace systems integrator trading at a significant valuation premium that continues to be the dominant investment concern. The stock has declined 4.6% from $779.62 to $743.67 since the prior report, compressing P/E from 58.76x to 56.10x and PEG from 2.10x to 1.96x — modest improvements but insufficient to reach a compelling entry point. Core financials remain strong: D/E of 0.15x (83% below industry average of 0.88x), $963M cash, ROE of 15.23% achieved without financial leverage, gross margin of 25.03% (55% above industry average of 16.15%), and revenue growth of 15.9% YoY. Q2 2026 results beat estimates with Non-GAAP EPS of $4.14 vs GAAP EPS of $3.61, and critically, free cash flow more than doubled year-over-year — a meaningful improvement from the -$38.5M FCF that was a prior concern. News sentiment remains exceptional at 95.8/100 with 7 of 9 articles positive, driven by European defense spending tailwinds and backlog visibility. However, the PEG of 1.96x remains 25.5% above the industry average of 1.56x, the analyst consensus target of $854.45 implies only 14.9% upside from current price, and forward EPS growth of 18.78% is 54.8% below the industry average of 41.55%. ESLT is a quality compounder in a sector of volatile peers — but quality alone does not justify paying nearly 2x growth-adjusted fair value.
Key Strengths
- Fortress balance sheet: D/E of 0.15x (83% below industry average of 0.88x), $963M cash, near-zero financial distress risk — provides strategic flexibility for acquisitions and R&D while peers are heavily leveraged; ROE of 15.23% exceeds industry average of 14.04% achieved entirely without financial engineering
- Dominant profitability vs. sector: gross margin 25.03% vs. industry 16.15% (+55%), operating margin 9.57% vs. industry -127%, net margin 7.44% vs. industry -294% — ESLT is a rare consistently profitable operator in a sector full of loss-makers, confirmed by Q2 2026 beat on both EPS and revenue estimates with Non-GAAP EPS of $4.14
- Exceptional news momentum (95.8/100 sentiment, 7/9 positive): European defense spending increases creating structural tailwinds for international business, Q2 2026 FCF more than doubled YoY addressing the prior FCF deterioration concern, and backlog visibility providing revenue predictability through 2029
Key Concerns
- Valuation remains materially elevated: PEG 1.96x (25.5% premium to industry 1.56x, ~96% above fair value 1.0x), P/E 56.10x on 7.4% net margins — analyst consensus target $854.45 implies only 14.9% upside, insufficient compensation for execution risk at this multiple; growth-adjusted fair value range remains $480-$600, implying 19-35% downside from current price
- Growth laggard vs. peers: forward EPS growth 18.78% vs. industry 41.55% (54.8% below average), revenue growth 15.9% vs. industry 50.77% (68.7% below average) — ESLT trades at a 25.5% PEG premium despite growing at roughly half the industry's forward EPS rate, a fundamental valuation disconnect that limits re-rating potential
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
ESLT's fundamentals present a classic quality-vs-valuation tension. On the quality side: D/E of 0.15x vs industry 0.88x (83% lower leverage), $963M cash providing strategic optionality, ROE of 15.23% vs industry 14.04% achieved without financial engineering, gross margin 25.03% vs industry 16.15% (+55% premium), operating margin 9.57% vs industry average of -127% (ESLT is among the rare profitable operators in this sector), and net margin 7.44% vs industry -294%. Revenue growth of 15.9% YoY and historical EPS growth of 39.8% demonstrate strong momentum. The critical FCF improvement — more than doubling YoY per Q2 2026 results — partially addresses the prior -$38.5M FCF concern, though the exact current FCF figure requires confirmation. On the valuation side: P/E of 56.10x is elevated even against the 21.2% five-year forward EPS growth expectation, yielding a PEG of 1.96x — nearly double the growth-adjusted fair value PEG of 1.0x. A fair-value PEG of 1.0x implies P/E ~21x; at current EPS backing into $743.67 at 56.10x = ~$13.26 EPS, fair value at 21x P/E = ~$278. Crediting a quality premium at PEG 1.5x (P/E ~31x) with forward EPS of ~$15.75 (18.8% growth) = ~$488. P/B of 7.91x is difficult to justify with ROE of only 15.23%. Analyst consensus target of $854.45 implies 14.9% upside — modest compensation for the valuation risk embedded at 56x earnings.
News Sentiment
Elbit Systems is riding a wave of strong momentum heading into the second half of 2026, but Wall Street analysts are pumping the brakes on enthusiasm — warning that the Israeli defense giant's excellent business may already be fully priced in. The company just reported its second quarter 2026 results, beating both earnings and revenue estimates according to multiple outlets. Non-GAAP earnings came in at $4.14 per share versus the GAAP figure of $3.61, reflecting the company's solid underlying profitability. Perhaps most importantly, free cash flow more than doubled year-over-year — a significant turnaround that addresses one of investors' biggest recent worries about whether the company's reported profits were actually translating into real cash. The backdrop couldn't be more favorable: European nations are dramatically ramping up defense budgets in response to ongoing geopolitical tensions, and Elbit — with its advanced military electronics, drones, and battlefield systems — is perfectly positioned to capture that spending surge. The company's international business is seeing structural tailwinds that could sustain growth for years. However, as one headline bluntly put it: 'Strong Q2 Results, Excellent Business, But Limited Upside.' With the stock trading near $744 and analyst targets clustering around $854, the upside math simply isn't compelling enough for new investors to chase the stock at current levels. The message from the Q2 earnings call was clear: the business is executing well, but the valuation already reflects much of the good news.
Risk Assessment
PRIMARY RISK: Valuation compression. At PEG 1.96x and P/E 56.10x, any growth disappointment or multiple compression toward industry average (PEG 1.56x, P/E 60.9x) could result in 20-35% downside. The stock is priced for sustained 21%+ EPS growth — any miss triggers disproportionate selloff. SECONDARY RISK: FCF sustainability. While Q2 2026 FCF more than doubled YoY (positive development), the prior quarter showed -$38.5M FCF; investors need to confirm this improvement is structural rather than timing-related. TERTIARY RISK: Geopolitical/regulatory. As an Israeli defense company, ESLT faces unique geopolitical risks including export license restrictions, regional conflict escalation affecting operations, and potential US/EU regulatory changes on defense exports. MITIGATION: The $963M cash buffer, 0.15x D/E, and record backlog provide meaningful downside protection. European defense spending tailwinds (NATO 2% GDP commitments) provide multi-year revenue visibility. Stop loss at $645 (-8% from $700 entry) limits downside to ~$55/share while targeting $154.45 upside to analyst target — R/R of 2.8x.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is ESLT a halal stock?
No, Elbit Systems Ltd. (ESLT) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for ESLT?
Elbit Systems Ltd. (ESLT) has a Plutrex AI rating of 65.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is ESLT a good investment?
According to Plutrex AI, ESLT has a Buy rating (65.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in ESLT?
US stocks like ESLT can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in ESLT?
Plutrex AI identifies the main risks for ESLT by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.